Literature DB >> 8281048

How "malignant" is the neuroleptic malignant syndrome?

M F Bristow, D Kohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281048      PMCID: PMC1679364          DOI: 10.1136/bmj.307.6914.1223

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Catatonia and the neuroleptic malignant syndrome--a single entity?

Authors:  D A White
Journal:  Br J Psychiatry       Date:  1992-10       Impact factor: 9.319

2.  The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.

Authors: 
Journal:  Br J Psychiatry       Date:  1991-05       Impact factor: 9.319

Review 3.  The treatment and management of neuroleptic malignant syndrome.

Authors:  S S Gratz; D F Levinson; G M Simpson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1992-07       Impact factor: 5.067

Review 4.  The neuroleptic malignant syndrome, so-called. A survey of the world literature.

Authors:  A M Kellam
Journal:  Br J Psychiatry       Date:  1987-06       Impact factor: 9.319

5.  Neuroleptic malignant syndrome: a study of CSF monoamine metabolism.

Authors:  K Nisijima; T Ishiguro
Journal:  Biol Psychiatry       Date:  1990-02-01       Impact factor: 13.382

Review 6.  Neuroleptic malignant syndrome. Review of response to therapy.

Authors:  M R Rosenberg; M Green
Journal:  Arch Intern Med       Date:  1989-09

Review 7.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

8.  Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients.

Authors:  P I Rosebush; T D Stewart; A J Gelenberg
Journal:  J Clin Psychiatry       Date:  1989-08       Impact factor: 4.384

9.  The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.

Authors:  A M O'Dwyer; N P Sheppard
Journal:  Psychol Med       Date:  1993-05       Impact factor: 7.723

10.  Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.

Authors:  D D Sewell; D V Jeste
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

View more
  5 in total

1.  High fever induced by sulphasalazine.

Authors:  S D Hearing; S Playfor; S J Bentley
Journal:  BMJ       Date:  1995-11-04

2.  Neuroleptic malignant syndrome. Don't confuse with anticholinergic intoxication.

Authors:  R Howells
Journal:  BMJ       Date:  1994-01-15

3.  Neuroleptic malignant syndrome. May be caused by other drugs.

Authors:  P M Haddad
Journal:  BMJ       Date:  1994-01-15

Review 4.  Neuroleptic malignant syndrome.

Authors:  P F Buckley; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

Review 5.  The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.

Authors:  M V Balzan
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.